Prudential Financial’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.59M | Sell |
19,250
-450
| -2% | -$36.1K | ﹤0.01% | 1485 |
|
|
2026
Q1 | $1.51M | Sell |
19,700
-22,740
| -54% | -$1.77M | ﹤0.01% | 1436 |
|
|
2025
Q4 | $3.35M | Sell |
42,440
-7,320
| -15% | -$634K | ﹤0.01% | 1073 |
|
|
2025
Q3 | $4.56M | Buy |
49,760
+31,710
| +176% | +$2.59M | 0.01% | 990 |
|
|
2025
Q2 | $1.18M | Buy |
18,050
+1,680
| +10% | +$109K | ﹤0.01% | 1603 |
|
|
2025
Q1 | $1.1M | Sell |
16,370
-670
| -4% | -$40K | ﹤0.01% | 1538 |
|
|
2024
Q4 | $942K | Sell |
17,040
-200
| -1% | -$11.5K | ﹤0.01% | 1594 |
|
|
2024
Q3 | $1.03M | Sell |
17,240
-1,310
| -7% | -$79.9K | ﹤0.01% | 1857 |
|
|
2024
Q2 | $1.18M | Buy |
18,550
+1,895
| +11% | +$123K | ﹤0.01% | 1731 |
|
|
2024
Q1 | $1.15M | Sell |
16,655
-715
| -4% | -$43.2K | ﹤0.01% | 1748 |
|
|
2023
Q4 | $958K | Sell |
17,370
-25,108
| -59% | -$1.38M | ﹤0.01% | 1841 |
|
|
2023
Q3 | $2.47M | Buy |
42,478
+22,315
| +111% | +$1.29M | ﹤0.01% | 1246 |
|
|
2023
Q2 | $1.09M | Buy |
20,163
+8,270
| +70% | +$367K | ﹤0.01% | 1775 |
|
|
2023
Q1 | $472K | Sell |
11,893
-410
| -3% | -$17.3K | ﹤0.01% | 2091 |
|
|
2022
Q4 | $495K | Sell |
12,303
-150
| -1% | -$5.63K | ﹤0.01% | 2028 |
|
|
2022
Q3 | $400K | Sell |
12,453
-975
| -7% | -$33.4K | ﹤0.01% | 2174 |
|
|
2022
Q2 | $398K | Sell |
13,428
-4,110
| -23% | -$119K | ﹤0.01% | 2223 |
|
|
2022
Q1 | $493K | Buy |
17,538
+1,550
| +10% | +$57.8K | ﹤0.01% | 2207 |
|
|
2021
Q4 | $737K | Sell |
15,988
-10,471
| -40% | -$450K | ﹤0.01% | 2025 |
|
|
2021
Q3 | $868K | Sell |
26,459
-15,427
| -37% | -$480K | ﹤0.01% | 1886 |
|
|
2021
Q2 | $1.47M | Sell |
41,886
-26,032
| -38% | -$886K | ﹤0.01% | 1637 |
|
|
2021
Q1 | $2.46M | Buy |
67,918
+25,685
| +61% | +$804K | ﹤0.01% | 1354 |
|
|
2020
Q4 | $1.23M | Buy |
42,233
+30,050
| +247% | +$861K | ﹤0.01% | 1651 |
|
|
2020
Q3 | $344K | Buy |
12,183
+143
| +1% | +$4.26K | ﹤0.01% | 2106 |
|
|
2020
Q2 | $389K | Sell |
12,040
-2,817
| -19% | -$101K | ﹤0.01% | 2014 |
|
|
2020
Q1 | $605K | Sell |
14,857
-241
| -2% | -$12.8K | ﹤0.01% | 1849 |
|
|
2019
Q4 | $931K | Sell |
15,098
-50
| -0.3% | -$3.31K | ﹤0.01% | 1879 |
|
|
2019
Q3 | $1.1M | Sell |
15,148
-3,670
| -20% | -$275K | ﹤0.01% | 1816 |
|
|
2019
Q2 | $1.55M | Buy |
18,818
+81
| +0.4% | +$5.76K | ﹤0.01% | 1712 |
|
|
2019
Q1 | $1.32M | Buy |
18,737
+1,088
| +6% | +$64K | ﹤0.01% | 1775 |
|
|
2018
Q4 | $795K | Sell |
17,649
-843
| -5% | -$44.2K | ﹤0.01% | 1882 |
|
|
2018
Q3 | $1.05M | Sell |
18,492
-1,530
| -8% | -$93.6K | ﹤0.01% | 1856 |
|
|
2018
Q2 | $1.34M | Buy |
20,022
+3,800
| +23% | +$237K | ﹤0.01% | 1813 |
|
|
2018
Q1 | $945K | Buy |
16,222
+1,172
| +8% | +$74.4K | ﹤0.01% | 1869 |
|
|
2017
Q4 | $970K | Sell |
15,050
-180
| -1% | -$11.2K | ﹤0.01% | 1851 |
|
|
2017
Q3 | $799K | Buy |
15,230
+1,280
| +9% | +$61K | ﹤0.01% | 1917 |
|
|
2017
Q2 | $653K | Sell |
13,950
-130
| -0.9% | -$6.27K | ﹤0.01% | 1965 |
|
|
2017
Q1 | $697K | Buy |
14,080
+200
| +1% | +$11.2K | ﹤0.01% | 1958 |
|
|
2016
Q4 | $841K | Sell |
13,880
-690
| -5% | -$42.2K | ﹤0.01% | 1891 |
|
|
2016
Q3 | $967K | Sell |
14,570
-4,130
| -22% | -$258K | ﹤0.01% | 1810 |
|
|
2016
Q2 | $1.04M | Buy |
18,700
+290
| +2% | +$14.1K | ﹤0.01% | 1814 |
|
|
2016
Q1 | $620K | Buy |
18,410
+400
| +2% | +$13.6K | ﹤0.01% | 1951 |
|
|
2015
Q4 | $813K | Sell |
18,010
-400
| -2% | -$17.2K | ﹤0.01% | 1842 |
|
|
2015
Q3 | $727K | Sell |
18,410
-620
| -3% | -$35.3K | ﹤0.01% | 1862 |
|
|
2015
Q2 | $1.18M | Buy |
19,030
+500
| +3% | +$29.8K | ﹤0.01% | 1762 |
|
|
2015
Q1 | $1.16M | Buy |
+18,530
| New | +$1.13M | ﹤0.01% | 1779 |
|
Other funds holding ANIP
SCM
TCM
GACM
Prudential Financial's ANIP Position: Q2 2026 in Review
Prudential Financial reduced its ANI Pharmaceuticals (ANIP) stake by 2.3% in Q2 2026, selling an estimated $36.1K and leaving 19,250 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.
Prudential Financial first reported a position in ANIP in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.56M in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Prudential Financial held 19,250 shares of ANI Pharmaceuticals worth $1.59M as of Q2 2026.
- Prudential Financial sold 450 ANI Pharmaceuticals shares in Q2 2026, an estimated $36.1K.
- ANI Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1485 holding.
- Prudential Financial first reported a position in ANI Pharmaceuticals in Q1 2015 and has held it in 46 quarters since.
- Prudential Financial's ANI Pharmaceuticals position peaked at $4.56M in Q3 2025.
- 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.